2023-12-31-accounts

Docusign Envelope ID". 3A6Ac3￿A-327￿A￿2-9o61-￿A3D78lD012E Co81ition for Coalition for Life-course Immunisation UKCh istration No: 1182662 Annual Re for the ort and Unaudited Financial Statement eriod ended 31 St December 2023 Coalrtion for Life-course Immunisation Registered Charity Number.. 1182662 Re8lStered UK Address: Horts House. 22.Whrtecourt. Uley GLII 5TG

Docusign Envelope ID". 3A6Ac3￿A-327￿A￿2-9o61-￿A3D78lD012E CoalrtM for Immunkatlo al and Administrative Information Boar(l of Trustees Daphne Holt Malcolm Taylor Trustees Cathenne Weil-OIivi8r Vytautas Usonis Anna Odone Gary Finnegan Elena Moya Penderia Joe Schmitt Francisco Gimenez-sanchez (appointsd 2211112023) Chair General Secretsry Samantha Nye Financial Signatory Ch 1182662 Chari Re istered N Coalition for Lrf&course Immunisation (CLCI) is16red Offic8 Horts Hous8 22. Whitecourt Uley GL115TG UK Bankefs Charilies Aid Foundation (CAF) Bank Kings Hill West Malling Kent ME19 4JQ Tele hone: [phone] Email.. Secretariat c]￿l.0r Website.. w￿.c1-Cl.O Page 2 of 18

Docusign Envelope ID". 3A6Ac3￿A-327￿A￿2-9o61-￿A3D78lD012E olition fty Lllty¢ourM Immunls¢ion Trustees Report for the Period ended 31 $1 December 2023 The accounts have been prepared in accordance with the accounting policies set out in note 1 to the accounts and Comply with the charity's Memorandum and Articles of Association and 'Accounting and Reportlng by Charities: Statement of Recommended Practice applicable to charities preparing their accounts in accordance with the Financial Reporting Stsndard applicable in the UK and Republic of Ireland {FRS102)" (as amended for accounting periods commencing from 1 January 2016). slon and Charltable Objectlves The CLCI is a membership organisation that brings t￿ether a netriork of organisations and individuals who support life-course immunisation and healthy aging. Our vision is Ihat all people whatever their means or background and of whatever age or stage of lrfe should have the opportunity to be protected against vaccine-preventable diseases- vaccination as a right not a privilege. Our mission is, beginning in Europe in the first instance, to identfy and share the best policies and practices regarding the lrfe-course approach to vaccination and to encourage their widespread adoption. CLCI seeks to educate and infomi patient groups, health care professionals. r8gulators, and polw makers of the benefits of widescale vaccination. The Need The Coronavirus pandemic, although waning, continues to bring the value of vaccinatil across the lrfe-course into the consciousness of policy makers and the PLtblic alike. N¢)w we must make sure that thls recognition continues viith routine vaccinations becoming the nomi. Low routine vaccFnation covorage in older people across most of Europe, variable vaccine recommendations between countries. incomplete data collection and reporting are indicative of variations in political will between countries to make this happen. A c(￿Certed European- wide effort is vital to change poliw and practice and to level up variable national vaccination coverage ratès to the highest possible level. Application of the lrfe-course approach will empower indlviduals to become more r85ponsible for their own health through the protection that immunisation confers. It also promotes Ihe expansion of vaccination delivery from the healthcare setting into the wider community, supporting all people, induding the most vulnerable. to a￿sS vaccination vthenever and wherever is convenient for them. Highor vaccination coverage also holds significant cost Savings for healthcare systems and hence society at large. whilst also promoting healthy aging. The CLCI manrfesto, developed for the new European Parliament in 2019, and titled '7 Steps to Life<ourse Immunis8tion', tYomot8S Strong leadership, making vaccination a societal 'nomi'. mobilizing healthcare workers, innovativg a¢c*ss, data-driven daeision making. fomiing broad coalilions. and budgeting for prevention. With the continuing backdrop of COVlfh19 our work is becoming even rrH)re important and lif&course immunization is ￿Eng increasingly disuJss8d by goveming b￿￿les. Page 3 of 18

Docusign Envelope ID". 3A6Ac3￿A-327￿A￿2-9o61-￿A3D78lD012E Coalth for LIft￿)ur1e Immyisiion Key Publlc Beneffts to our Work The Trustees have (x)m￿led wtth the duty in section 4 of the 2006 Charities Act to have due regard to guidance published by the Charity Commission. Greater aw8reness at all lev81s of society, policy makers, healthcare professlonals and the public alike, of the benefits of vaccination at all ages and slages of lrfe. A higher profile of vacanation across the lrfewcourse as a key public health priorlty, paving the way for our rnember organisations to increase access to res￿rceS in their countrres. Access to a nelwork of experts and that allows wlicy makers to enhance their own work. Opportunities for the voices of members to be heard by policy makers, key opinion leaders and the public. General recognition that wide-spread access to vaccination promotes societal health by enhancing wotection of all people at all ages and stsges of life. The main vehicles which help us carry out our work are the production of position papers and policy documents. seminars and webinars which raise awareness in healthcare professionals, policy makers and civil society," and infomation and communication campaigns. All of these acttvities are designed to create a positive momentum to increase the uptake of vaccines and save lives. Achlevements and perforniance Actlvltles In 2023 After a great year in te￿8 of both achievement and ftjnding in 2022, the Coalition for Lrfe- course Imrnunisalion (CLCI) has continued lo build in 2023. The Belgium-based sister organisation is now registered, has an operational bank account and has become the major recipient of fijnding and source of charitsble activities in 2023. Additionally, funding was available from 2022 grants from Sp￿SOrs whith was used io support UK-based project proposals ac*ivities in 2023. The amount raised vms a little short of the h)pe&for budget it has 5ti11 meant thaL" CLCI is again sustsinable into the next financial year (2024) The reputation of CLCI has deepened due to the continuation of its innovative way ofthinking CLCI is grateful to all its sponsors, and their support has allowed the organisalion of events, preparation of reports, representation at Europe8n events and working groups, expansion of MEP engagwnent. and enhanced Communications. The one setback was the loss early in the year of the senior policy and research officer, seconded from CLCI member Intemational LorwJevity Centre {ILC UK), vtho resigned from ILC UK. However, the scfjpe of the work has ￿en covered very well, albeit in a different manner, by Sandra Evens of SE Health Poli Page4of18

Docusign Envelope ID". 3A6Ac3￿A-327￿A￿2-9o61-￿A3D78lD012E Immunisalion Events and Reports: At the beginning of the year 2023 CLCI launthed its interactive Pneumococcal Atlas in Bnjssels, built in collaboration with ILC UK. and published the accompanying ￿re ort. In June 2023, we held a round table discussion in the European Partiament and published a report Refocusin on ublic he&lih and makin anim act on adult vaccination from a life course ers eclive. At this meeting a call to action was proposed to form an MEP Interest Group on Lrfe Course Immunisation ILCI), endorsed by MEPS Tomislav Sokol and Cyrus Engerer, to translate the ideas discussed at Ihe roundtable Into coordinated Eu-level action. We also built a resource pack available on Ihe CLCI website via a QR code- a small new innovation for CLCI. We have successfully launched a odcasl series. another innovation, in collaboration with Global Health Press, on the COVID pandemic, where CLCI board members Professors Joe Schmitt and Catherine Weil-olivier spoke to Seading vaccine and virology experts in Europe to understand what COVID has meant for our health systems and what the future holds. Thus far we have published GOVID-19- Update on Win)logy with Professor Bruno Lina. Long Covid with Professor Danny Altmann, Improving COVID-19 Vaccine Confjdence.. What Science Tells Us with Dr. Emilie Karafillakis. COVID-19 Vacunalion in Peace Time with Professor Pier Luigi Lopalco. and COVID-19 Experience in Children with Professor Federi Marknnon Torres. A final episode will be recorded for release In late OctoLEr followèd by a round-up report by year end. Continuing its missFon of working wrth others to meet its objectives, CLCI has co15aborated wilh the Active Citizenship Network to condud tts first foreign language workshop with expert5 in France. The workshop, L3 SOGielé civile favorisanl la vaccination toul au lon de la vic (Civil society promoting vaccination throughout life). was led by CLCI board member Professor Catherine Weil-olivier with the support of Sandra Evens. It is expeded that a report will follow in both French and English. The major event for 2023, the CLCI Members Summit on Life Course Immunisalion, look pla￿ on 22 -24 November in Ameria, Spain in collaboration with a CLCI member.. The 831mis Inslitule. The summit brought logelher the CLCI fflembership, extemal experts and stakeholders to explore solutions and strategies to pave the way fobward and ullimatety inform Ihe 2024-2029 CLCI manifesto for the new European Padiamenl in 2024, and the program features a range of relevant and important dialogues. A round-up report will be published after the event. External engagement: In addition to the Work reported above, CLCI has been represented at a variety of webinars and meetings. as well as ￿ntributIng to health reports: Page5of 18

Docusign Envelope ID". 3A6Ac3￿A-327￿A￿2-9o61-￿A3D78lD012E Co8lltlon for Lif+coufS• Imfftunis¥tlon Stren Ihenin Health Mana the EU vaccine ecos ement As iation slem.. mana th ital transformation- Euro ean Enablin FIP olic lif&course Immunisation throu toolkit- Federation of Inlernati h harmac nal Phami -based vaccination.. La cists nchofan Euro e's TOMO￿ow.. Vaccination and Prevention Summit- Think Youn he burden of RSV.. A th to awareness in Euro DH has also contributed to a podcast on pertussis and a paper on migrant health. both as yet unpublished. - EAfPA In 2023 CLCI also became a member of the PROTECT- Euro European Mission Board on Vaccination. e advisory board and the Communlcatlons: The new CLCI web sile is now live and sportlng the refreshed logo. The CLCI Linkedln and x￿wItter followings have continued to increase, along with regu18r posts on Linkedln and quarteTty newsletters. Structurey govgrnance, and management The CLCI is a charitable incorporated organisation (Cloy registered with the Charity Commission in England and Wales and as an Association sans But Lucrative (ABSLI in Belgium The trust88s who served during the 2023 are listed under the Legal & Administrative Infomation. As required by the articles of as$￿tatiOn Gary Finnegan and Catherine Weil-oliver resigned at the 2023 AGM and offered themselves for r&election. Additionally, Francisco Gimenez-sanchez offered himself for election to Ihe Board. Ernail voting was available for those not at the AGM and so final resulls were announced after the end of th8 voting period; all three candidates were elected. Trustees must be members of CLCI in order to be eligible for eledion. The trustees rnanage the business of the charity and may exercise all the powers ofthe charity unless they are subject to any restrictions imposed by the articles or any special resolution. All trustees give of their time freely and no trustee remuneration was paid in 2023. Trustees are required to disdose all relevant interests and regisl8r them wilh the General Secretary. In accordance with the charity's policy, trustees will wthdraw from discussion leading to decisions where a conflict of interest may arise. Page6of 1B

Docusign Envelope ID". 3A6Ac3￿A-327￿A￿2-9o61-￿A3D78lD012E Volit￿n ltsr llfvcou￿thmunts•IIOn Finan￿ & Funding Flnanclal Roview The figures quoted here have been examined by an Independent Examiner and will be submitted to Ihe England & Wales Charty Commission. The total amount of restricted reserves carried over continues to be high because activities have necessarity been disrupted du8 to the ¢ontinuing health crisis. CLCI'S efforts to diverstfy its funding in order to provide a more sustainable base for Its activities has continued. Following the organisational access changes wilhin the EU following Brexit, the majority of grants in 2023 were lo its Belgium-based sister organization. Nevertheless. CLCI {UK} was able to fund acttvities arising from grants received in 2022 and was able to secure unrestricted grants. as well as gffts in kind in 2023. Principal Fundlng Sources CLCI has secured funding from unrestricted grants. alC￿g with gifts-in-knnd from a trustee. Since CLCI is a membership organisation, avoiding competing for funding with our members is a key f8Ctor and d￿$ create ￿rtain limitations to where we can source our funds. Investment Pollcy Aside from retaining a prudent amount in reserves each year, all of the charity's funds arè to be spent in the short term or are restricted to long-temi projects currently in progress. Therefore, CLCI does nol have any investments or material assets. Rlsk Fact The trustees h8ve assessed the major risks to whith the Charity is exposed and are satisfied that s￿ems are in place to mitigate exposure to the major risks. Risks may relate to govemance, operational factors, finance. exlernal factors OT Complian￿ with law and regulation. Such assessment processes will include horizon scanning for new risks. Th6 trustees Te¢ognize the need to diversify funding support and actively work to mitigate tho risk of becoming over4ependent on any one sour￿. The trustees also recognize Ihe need to have some free reserves. Furthermore, the trustees recognize the need to separate management and govemance and this continues to be c1058ly monitored. Future Actlvltles Before 310t December 2024, as funds allow, and subject to legal and financtal advice CLCI will Ensure sustainabitity into 2025 Develop a proposal for transfer of the organisation and its merger with the Belgium- based sister organisalion in 2025. Page 7 of 18

Docusign Envelope ID". 3A6Ac3￿A-327￿A￿2-9o61-￿A3D78lD012E Co*llllon for Immunis¥tion Statement of trusteos, responsibilities Law applicable to charities in England & Wales requires the trustees lo Prepa￿ a financial slatement for each financial period which give a true and fair view of the charitys financial activilies during the period and of its financial posilion at the end of the period. In preparing financial ￿atements giving a true and fair view, the Trustees should follow best practice and: select suitable a￿oUntIng policies and then apply them consistently. observe the methods and prinaples in the Charities SORP. make judgements and estimates that are reasonable and prudent. state whether applicable UK Accounting Standards and statements of re￿rnMended practice have been followed, suty'ect to any material departures disdosed and explained in the finanaal statements. prepare the financial statements on the going concem basis unless it is inappropriate to presume that the charity will corrtinue in business. The Trustees are responslble for keeping adequate accounting records that disclose with reasonable accuracy at any time the finanual position of the charrty and enable them to ensure the financial statements comply with the Charities Act 2011. They are also responsible far safeguarding the assels ofthe charity and hence fortaking reasonable st8ps the prevention and detection of fraud and other irregularities. The Trustees are responsible for the malntenance and integrity of the charity and financial informats'on included on the charity's website. Legislation in the United Kingdom goveming the preparation and dissemination of financial statements may differ from legislation in other jurisdictions. Approved by the Board of Trustees and signed on its behalf by: Malcolm Taylor General Secrotary Dated Pag?8of 18

Docusign Envelope ID". 3A6Ac3￿A-327￿A￿2-9o61-￿A3D78lD012E Co•litlon for Corrigan Management Letter Independent Examlnefs Report to the Trustses of Coalttion for Life<ourse Immunisation I report to the charity trustees on my examination of the accounts of thè charity for the period ended 31 December 2023 which are set out on pages 10 to 18. Rosponslbllltlos and basis of report As the charity's trustees you are responsible for the preparation of the accounts in 8ccord8nce with the requiremenls of the Charibes Act 2011 (Ihe Act.). I report in respert of my examination of the charity's a￿unts carried out under section 145 of the Act and in carying out my examination I have followed all the applicable Directions gwen by the Charity Commission under section 145{5)(bl of the Act. Independent examinevs ststement I have compleled my examination. l 0)nfi￿ that no materlal matters have come to my attention in connection wth the examinatton giving me cause lo believe that in any fflaterial respect: accounting records were not kept in respect of the charity as required by section 130 of the Act. or Ihe accounts do rM)t accord those records. or the accounts do not CA)mply wth the applicable requirements concerning the form and content of accounts set out in the Charities (Accounts and Reports) Regulations 2008 other than any requirement that the accounls give a 'true and fair view, which is not a matter considered as part of an independent examination. I have no concerns and have come across no other matters in connection with the examination to ￿lCh attention should be drawn in this report in order to enable a proper undarslanding of the accounts to be reached. Signed: Edward Corrigan FCA Corrigan Accountants Limited 1st Floor 25 King Street Bristol BS14PB Date.. Corrigan Accountsnts Limlted 28-Oct-24 Pmge 9 of 18

Docusign Envelope ID". 3A6Ac3￿A-327￿A￿2-9o61-￿A3D78lD012E i)•lltlon for lil￿oU￿￿4 Immuni$4don STATEMENT OF FINANCIAL ACTIVITIES INCLUDING INCOME AND EXPENDITURE ACCOUNT FOR THE PERIOD ISI January 2023 to 31¥1 December 2023 Unrèstricted Funds £ 2023 Restricted Funds £ 2023 Total £ 2023 Total £ 2022 Income From: Donations and Grants 8500 8500 51.515 Gifts in Kind Interest Total In¢om• ndlture On: Charitable Activities Su ort costs Total resources ended 293 83 293 83 5,615 57 44,216 275 44,491 44,216 2.528 46,744 30,949 2,822 33,771 2,253 2,253 Net (outgoing)lincomlng resources 6,623 (44,491) (37,868) 23,416 Net movement in funds 6,623 (44,491) (37,868) 23.416 Fund balances at 1st Janua 2023 (7,959) 70.635 62,676 39.260 Fund balances at 31#t December 2023 (1,336) 26,144 24,808 62,676 The statement of financlal acdvlties indudes all galns and losses rèco3nised in the peric*l. All income and axpenditure derive from continuing actNiti'es. P8gelOof18

Docusign Envelope ID". 3A6Ac3￿A-327￿A￿2-9o61-￿A3D78lD012E alldon for STATEMEKf OF FINANCIAL POSITION AS A T 31st December 2023 2023 2022 Notes Current assets Debtors Cash at bank and in hand 26,848 62,275 Creditors: amounts falling due within one ear 2,040 2,000 Net current assets Income funds Restricted funds Unrestricted funds 26,144 1,336 70.635 7,959 The CIO is entitled to exemption from audit urmder S8clion 144 of th8 Charities Act 2011 for the period ended 31 DecEmber 2023. The members have not required the Cofnpany to obtaln an audit of lis financlal slatements for the p8ri1Jl ended 31 December 2023. The trustees acknovAedge their responsibilities for 8nsuring that the company keeps aGGounting records vthith comply wtlh section 137 of the Charit18s Act 2011. The financial ststements were approved by the Board of Trustees, and authorised for issue, on and were signed on its behalf by: Malcolm Taylor Dated: General Secretary Page 11 of 18

Docusign Envelope ID". 3A6Ac3￿A-327￿A￿2-9o61-￿A3D78lD012E Ccjalltlon for Liffrcouts• Imfflunis•tlon NOTES TO THE FINANCIAL STATEMENTS FOR THE PERIOD ENDED 31st December 2023 1. Aecountlng policies Charlty Infomiation The Coalltlon for Life-course Immullisation is a charitable incorporated organisation registered wtth the England and Wales Charity C¢)mmission. The regislered office is Horts House, 22 Whitecourt. Uley. GL115TG, UK. 1.1 Accounting convention The accounts have been prepared in accordance with the charity's Artides of Asso(ialion and "Accounting and Reporting by Charities.. Statement of Recommended Practice applicable to charities preparing their accounts in accordance with the Financial Reporting Standard applicable in the UK and Republic of Ireland {FRS 102)" {as amended for actounting periods commencing from 1 January 2016). The charity is a Public Benefit Enlty as defined by FRS 102. The financial ststements are prepared in sterling, which is the functional currency of the charity. Monetary amounts in these financlal ststements are rounded to the nearest £. The financial stat8ments hav8 been prepared under the hlstorical cost convention, modified to include the revaluation of freehold properties and to indude investment properties and certain financial instruments at fair value. The princFpal accounting policies adopted are set out below. 12 Golng concern At the time of approvlng the financial stalements, the trustees have a reasonable expectstion that the charlty has adequate resources to continue in operational existence for the foreseeable futur6. Thus, the trustees continue to adopt the going concem basis of accounting in preparing Ihe financial statements. Funding in the current dimate has been carefully considered and w8s raised for discussion at all trustee meetings but was not considered to cause significant difficulties for the charity in this regard. 1.3 Fund accounllng Unrestricted funds arè available for use at the discretion of the trustees in furth8ranoe of their charitsble objedives unless the fvnds have been designated for other purposes. Restricted funds are subject to specffic conditions by donors as to how Ihey may be used. The purposes and uses of the restricted ftjnds are set out in the notes to the financial ststements. Page 12 ￿ 18

Docusign Envelope ID". 3A6Ac3￿A-327￿A￿2-9o61-￿A3D78lD012E Ulwoum Immunlsatlon 1.4 Incomlng rosourcos Income is recognised when the charity is18gally entilled to it after any perfomiance conditions have been met, the amounts can be measured reliably, and it is prObat￿e that income will be re￿ived. Cash donations are recognised on r￿Ept. Other donations are recognised once the charity has been notsfied of the donation unless perft)rmance conditions require deferral of the amount. Income tsx recoverable in relation to donations received under Gift Aid or deeds of covenant is recognised at the time of receipt from HMRC. Legacies are recognised on receipt or otherwsse if the charity has been notrfied of an Impending dislribution, the amount is known, and receipt is expected. If the amount is not known. the legacy is treated as a contingent asseL Tumover is measured at the fair v81ue of the consideration received or receivable and represents amounts receivable for goods and seniices provided in the nomal course of business. net of discounts. 1.5 Resources exponded Income and expenses are included in Ihe financial ststements as Ihey become re￿Ivable or due. Expenses include VAT where applicable as Ihe charity cannot reclaim it. 1.6 Cash and cash equlvalents Cash and cash equivalents include cash in hand, deposits held at call with banks, other short- term liquid investments with original maturilies of three months or less, and bank overdrafts. 1.7 Flnanclal Instruments The Charity has applied the provlslons of Sectlon 11 'Basic Financial Instruments, and Seclion 12 '0ther Financial Instruments Issues, of FRS 102 to all of its financial instruments. Financial instmments are recognised in the charitys b81an¢e sheet vthen the charity become5 paty to the contractual provisions of the instrument. Financial assets and liabilities are offset. wth the net am¢)unts wesenled in the financial stslements, when there is a legally enforceable right to set off the recognised amounls and there is an intention to settle on a net basis or to realise the asset and settle the liability simultaneously. Baslc flnanclal assets Basic financial assets, which indude debtors and cash and bank balanc6s, are initially measured 8t transaction price induding transaction costs and are subsequently carried at amortised cost using the effective interest method unless the affangement constitutes financing transaction, vthere Ihe transaclion is measured at the present value of the future receipts discounted at a market rate of interest. Financial assets classffi&J as receivable within one year are not amortised. Pagg13of 18

Docusign Envelope ID". 3A6Ac3￿A-327￿A￿2-9o61-￿A3D78lD012E Co*lirfon for Bas1¢ financlal Ilabllftles Basic financial liabilities. including creditors and bank loans are inrtially recognised at transaction price unless the arrangement constitutes a financing transaction, where the debt instrument is measured at the present value of the future payments discounted at a market rate of interest. Financial liabilities dassffied as payable viithin one year are not amortised. Debt instruments are subsequently carried at arnortised cosL using the effective interest rate method. Trade creditors are obligations to pay for goods or services thal have been a(4uired in the ordinary course of operations from suppliers. Amounts payable are dassified as current liabilities rf payment is due within one year or less. If noc they are presented as non-current liabilities. Trade creditors are recognised initially at transaction price and subsequently measured at amortised cost using the effective interest metht)J. D•recognltlon offlnanclal Ilabllltles Financial liabllities ar8 d8recognlséd when the charity's contractual obligations expire cff are discharged or cancelled. 1.8 Allocatlon of support costs Support costs aré these functions that assisl th8 Work of the charity. trAJt do not directly undertake charitable activities. Support costs indude back-office costs, finance. personnel. 8nd governance costs. which support the charivs projects and activities. 2. Crltlcal accountlng ostlmatos and Judgements In the applicatK)n of the charity's accounting policies. the trustees are required to make judgements, estimates and assumptions about the carrying amount of assets and liabilities that are not readily apparent from other sources. The estimates and associated assumptions are based on historical experience and other factors that are considered to be relevant. Actual results may diffèr from these estimates. The estimates and underlying assumptions are reviewed on an ongoing basis. Revisions to accounting estimates are recognised in the period in which the estimate is revised where the revision affecls only that period, or in Ihe period of the revision and future periods where the revision affects both current and future periods. Page 14of18

Docusign Envelope ID". 3A6Ac3￿A-327￿A￿2-9o61-￿A3D78lD012E Coalilion lor 3. Donations and lega¢l8s Unrestrlcted funds Restricted funds Total 2023 Total 2022 Donations and tfts Private donations Gift-in-kind below CAF Bank interest EFPIA Grant prizer MSD grant Communic8tions & emenl strate MSD Grant for COVID-19 media Cam ai 8500 293 83 85C() 293 83 5,615 57 20.363 24,460 Totals 8,876 8,876 57,187 Glfts In Klnd 2023 2022 EIP Conference Website Costs EIP rt costs Website month 2,037 182 G suite 293 293 Charftable actmtles Advocacy £ 2,528 Membership £ Total 2023 £ Total 2022 £ 2,822 Support costs (note 5) Research Manager ILCUK & SEHPL SEHPL preparation of ublications AGM website & Office costs GIK RockGoat media su ort Webinar reporting costs Sandra Evans Design & Printing of Digital Pandemic ort Totals 2,528 31,438 31,438 23,957 1.000 4,550 4,550 5,432 3,067 3,(￿7 5.161 5.161 560 46,744 46,744 33,771 Ppge 15of18

Docusign Envelope ID". 3A6Ac3￿A-327￿A￿2-9o61-￿A3D78lD012E Co8l•tion for Analysis by funds Unrestricted 2,253 44,491 46.744 2,253 44,491 46,744 2,622 31,149 33,771 Restricted 5. Support costs Support costs £ Governanee costs £ 275 Tolal 2023 £ Total 2022 £ AGM Secretarial su ort costs CAF monthly account costs CAF Forex fees Website su rt costs Independent examination Research manager travel and subsistence for Brussels Dig Pandemic Meetin Totals 275 182 60 60 81 18 413 413 1,780 1,780 1,900 641 413 6. Debtors 2023 £ 2022 £ 2,401 Prepayment of ILC{UKI secondment ment for Janua 2023 Totsls 2,401 7. Creditors 2023 £ 2022 £ 2,000 Accruals Totals 2,000 Page 16of18

Docusign Envelope ID". 3A6Ac3￿A-327￿A￿2-9o61-￿A3D78lD012E Co*llll¢)n for LIIKows• Immunlsadon 8. Restrlcted funds The Income funds of the charity inrjude restricted funds comprising the following unexpended balances of donations arKI grants held on trust for specrfic Purposes: Balance atlJan 2023 Incomlng resources Resources expended Balance at 31 Dec 2023 Balmis Conference Fundin prizer grant for World Con ress Public Health Sanofi Pasteur grant IQO,000) for 3 posilion Papers & the published inion iece MSD grant Chronic Diseases Pro MSD grant Communications & emenl strate EFPIA Grant MSD Grant for COVID-19 media cam ai Total 824 824 7.363 {4,300) 3063 7.382 7,382 1.021 {908) 113 12,286 (12,286) 14.478 14,478 44,491 Balmls Conference This fund was used for CLCI to attend and present at th8 Balmis Institute Conference in December 2019. The Pfizer grant for World Congress on Public Health This grant was used to organise and prgsent a workshop at the WCPH on the theme of'Life Course Immunisation- a W8St8m Concept or a Global Goal?, and a subsequent write-up. Sanofi Pasteur This grant was used to create 3 Position Papers on aspects of Lrfecourse Imrnunisation and an opinion piece which would be submitted for publication. MSD grant for Chronlc Dlseases Prolect In 2020, MSD kindly provided us with a grant to support work atM)ut increasing uptake of vaccines, Working organisations concemed with chronic diseases. MSD grant Communlcallons & Engagoment strategy This covered the development of a new website. activities by the seconded (ILCUK) research manager using Linkedln arKf Twitter {X) and publication of digital newsletters. Page 17of18

Docusign Envelope ID". 3A6Ac3￿A-327￿A￿2-9o61-￿A3D78lD012E Coaiitrtin f EFPIA Grant EFPIA kindly agreed to a grant to support CLCI in its core goal of vaccination for all thr(wJgh: promoting resilience in healthcare syslerns,. addressing the challenge of the 'vaccine infodemic,; laying foundations for the possible formation of an MEP interest group on lif course immunisation,. & updating our manifesto in the light of what has been leamed in the face of the Covid-19 pandemic. MSD Grant for COVID-19 medla campalgn In 2021, MSD kindly agreed a grant which allowed us to undertake the COVID & Beyond campaign which covered an intertm survey and report in 2021 and then a final report, which was launched in 2022. 9. Related party transactlons The trustee, Malcolm Tafvr, donated gifts in kind totalling £293 (2022- £182). 10. T￿￿te•S None of the trustees (or any persons connected with them) received any remuneration nor were rewnbursed any gxpenses during the perlod. 11. Employees There y￿re no 8mployees during the perfod. Page 18 of 18

Docusign Certificate Of Completion Env8lop8 Id.. 3A6AC3BA327D4AE29061BA3D781 D012E Status.. Completed Subjèct." Complete with Docu8tqn." Coalition for Lrfe£ourse Immunisation SIGNED ac(x)unts 31.12.23 IIE rep... Source Envelope.. Document P8ges'. 18 C8rtlflcal6 P8ges'. 1 AuloNav". Enabled Envelopeld Stamping.. Enabled Time Zon8'. IUTCI Dublin, Edinburgh, Lisbon, London Signatures.. 1 Envelope Originator.. Cathy N&ch 1st Flwr. 25 King Street Bristol. BS14PB [e-mail] IP Address." 82.40.250.127 Record Tracking Stalu8'. Original 1012812024 11."21."12 AM Holder.. Cathy Nech calhy.nÈ[e-mail] LocalM)n.' Docusign Signer Events Signature Timostamp Sent.. 1012812024 11'.23.'23 AM View8d". 1012W2024 12".09".19 PM Edward Corrigan [e-mail] Signed. 1012812024 12..10.13 PM Corrigan Accountsnls Ltd Sacurlly Lev81.' Email, Account Aulh8nllc8tlon (Noné) Signature AdoptK)n". Uploaded Signature Imagè Using IP Addre5s'. 193.178.112.254 Electronic Record and Signature Di5closure- Not Offered via Docusign In Person Slgner Events Slgnature Tlmestamp Editor Delivery Events SL*us Timestamp Agent Delivery Events ststus Timestamp Intgrniediary Delivery Events ststus Timgstamp Certified Delivery Events Status Tirnestamp Carbon Copy Events Status Timestamp Witness Events Signature Timestamp Notary Events Slgnature Tlmestamp Envelope Summary Events ststus Timestamps 1012812024 11".23".24 AM EnvÈlope Sent Certifie(l Delivered Signing Complete Complel&d HÈshedlEncrypled SeGurity Checke(I Security C￿￿ked Security Ch8ck8d 1012812024 12."09..19 PM 1012812024 12..10..13 PM 1012812024 12.-10'.13 PM Paymgnt Evgnls ststus Timgstamps